English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 1, 2025

Research advocates new diagnostic approach for Langerhans cell histiocytosis
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Man survives heart attack with help from UTHealth Houston cardiologist
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

UTHealth Houston unveils new institute to enhance surgical safety
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Living pain-free with MS: A focus on modern treatment breakthroughs
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

MIT's Sally Kornbluth to speak at Baylor College of Medicine's commencement in May
+ Regulatory
Patient Daily News Service | Mar 28, 2025

Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.
+ Pharmaceuticals
Patient Daily | Mar 28, 2025

Experts propose new framework for managing persistent chylomicronemia

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones